SEC Form 4 · accession 0001179110-17-006289
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph J Manning
Officer — Senior Vice President
Period of report
Apr 26, 2017
Accepted (ET)
Apr 28, 2017 · 5:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Apr 26, 2017 | M | 3,200 | $26.6973 | A | 26,224 | D | |
| Common shares without par value | Apr 26, 2017 | S | 200 | $43.94 | D | 26,024 | D | |
| Common shares without par value | Apr 26, 2017 | S | 100 | $43.941 | D | 25,924 | D | |
| Common shares without par value | Apr 26, 2017 | S | 100 | $43.943 | D | 25,824 | D | |
| Common shares without par value | Apr 26, 2017 | S | 500 | $43.945 | D | 25,324 | D | |
| Common shares without par value | Apr 26, 2017 | S | 2,300 | $43.947 | D | 23,024 | D | |
| Common shares without par value | Apr 26, 2017 | S | 400 | $43.971 | D | 22,624 | D | |
| Common shares without par value | Apr 26, 2017 | S | 600 | $43.973 | D | 22,024 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F1 | $26.6973 | Apr 26, 2017 | M | 3,200 | D | Feb 15, 2011 | Feb 14, 2018 | Common shares | 3,200 | 0 | D |
Explanation of responses
- F1Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.